Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mereo BioPharma Group (MREO) Non-cash Items: 2022-2024

Historic Non-cash Items for Mereo BioPharma Group (MREO) over the last 3 years, with Dec 2024 value amounting to $15.8 million.

  • Mereo BioPharma Group's Non-cash Items fell 79.73% to $4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 million, marking a year-over-year decrease of 79.73%. This contributed to the annual value of $15.8 million for FY2024, which is 94.02% up from last year.
  • Latest data reveals that Mereo BioPharma Group reported Non-cash Items of $15.8 million as of FY2024, which was up 94.02% from $8.1 million recorded in FY2023.
  • Mereo BioPharma Group's 5-year Non-cash Items high stood at $15.8 million for FY2024, and its period low was $6,000 during FY2022.
  • Over the past 3 years, Mereo BioPharma Group's median Non-cash Items value was $8.1 million (recorded in 2023), while the average stood at $8.0 million.
  • Data for Mereo BioPharma Group's Non-cash Items shows a peak YoY surged of 135,266.67% (in 2023) over the last 5 years.
  • Mereo BioPharma Group's Non-cash Items (Yearly) stood at $6,000 in 2022, then soared by 135,266.67% to $8.1 million in 2023, then soared by 94.02% to $15.8 million in 2024.